retatrutide clinical trial obesity Eli Lilly infiltrates anti-obesity market as Phase III for begins retatrutide clinical trials efficacy (RETA)

Do I need to be a member

Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimers disease

Ozempic and the Risk of nAMD A recent article in JAMA Ophthamology (June 2025) suggests that vascular changes triggered by GLP-1 activity may trigger or worsen nAMD in some patients, especially those who are older, diabetic, or already at risk for macular degeneration

Oar emphasizes empowerment and destigmatization, framing alcohol reduction as a personal health choice rather than emphasizing alcohol use disorder as a sign of dependency or failure